Corcept Therapeutics (CORT) Non Operating Income (2018 - 2025)
Historic Non Operating Income for Corcept Therapeutics (CORT) over the last 8 years, with Q3 2025 value amounting to $5.0 million.
- Corcept Therapeutics' Non Operating Income fell 2081.95% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.9 million, marking a year-over-year decrease of 17.84%. This contributed to the annual value of $24.5 million for FY2024, which is 4206.66% up from last year.
- Latest data reveals that Corcept Therapeutics reported Non Operating Income of $5.0 million as of Q3 2025, which was down 2081.95% from $5.0 million recorded in Q2 2025.
- Corcept Therapeutics' Non Operating Income's 5-year high stood at $6.7 million during Q4 2024, with a 5-year trough of $72000.0 in Q3 2021.
- Its 5-year average for Non Operating Income is $3.3 million, with a median of $3.6 million in 2023.
- As far as peak fluctuations go, Corcept Therapeutics' Non Operating Income crashed by 8910.89% in 2021, and later surged by 437625.0% in 2023.
- Quarter analysis of 5 years shows Corcept Therapeutics' Non Operating Income stood at $72000.0 in 2021, then skyrocketed by 2368.06% to $1.8 million in 2022, then soared by 189.25% to $5.1 million in 2023, then soared by 30.31% to $6.7 million in 2024, then dropped by 24.99% to $5.0 million in 2025.
- Its Non Operating Income stands at $5.0 million for Q3 2025, versus $5.0 million for Q2 2025 and $6.2 million for Q1 2025.